Drug delay sends firm's shares into second spiral
ic Liverpool, UK - 44 minutes ago
US licence request for Voraxaze, which helps cancer patients experiencing toxicity from methotrexate, after the US Food and Drug Administration (FDA) demanded
US delay for drug that eases side-effects of chemotherapy Times Online
all 8 news articles